Understanding how early pancreatic cancer lesions interact with their environment
Tumor Microenvironment Crosstalk Drives Early Lesions in Pancreatic Cancer
This study is looking at the early signs of pancreatic cancer to understand how early changes in the pancreas interact with their surroundings, which could help find ways to detect the cancer sooner and improve treatment options for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10922841 on NIH RePORTER |
What this research studies
This research investigates the early stages of pancreatic cancer, focusing on how non-invasive precursor lesions communicate with their surrounding environment. By studying the molecular dependencies and signaling cues from these lesions, the research aims to uncover potential early detection methods for pancreatic ductal adenocarcinoma (PDAC). The team utilizes advanced techniques to analyze the interactions between precursor lesions and associated fibroblasts, which may play a crucial role in cancer progression. Patients may benefit from insights that could lead to earlier diagnosis and intervention strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with early-stage pancreatic lesions or those at high risk for developing pancreatic cancer.
Not a fit: Patients with advanced-stage pancreatic cancer or those without any precursor lesions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and treatment options for pancreatic cancer, potentially improving patient outcomes.
How similar studies have performed: Previous research has shown promise in understanding the biology of pancreatic lesions, indicating that this approach could yield valuable insights.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Maitra, Anirban — University of Tx Md Anderson Can Ctr
- Study coordinator: Maitra, Anirban
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.